Gadolinium-based contrast agents (GBCAs) have helped to improve the role of magnetic
resonance imaging (MRI) for the diagnosis and treatment of diseases. There are currently …

A contrast agent can substantially improve the diagnostic quality of magnetic resonance
imaging. Gadolinium-based contrast agents are a very similar class of pharmaceuticals. But …

Gadolinium-based contrast agents (GBCA) have played a pivotal role in enhancing the
diagnostic capabilities of MRI for several decades. The application of gadolinium as a …

Background To date there is no agreement as to what is the optimal concentration for
gadolinium-based contrast agents (GBCAs). Purpose To assess whether diagnostic …

In the past three decades, we have learned much about the potential short-term and long-
term safety issues associated with the intravenous administration of gadolinium based …

Contrast agents is used in magnetic resonance imaging (MRI) to improve the visibility of the
details of the organ structures. Gadolinium-based contrast agent (GBCA) has been used …

Gadolinium-based contrast agents (GBCAs) are widely used in MRI to increase the visibility
of tissues. Some believe, however, that due to their documented toxicity, clinical use of these …

Accurate detection of lesions throughout the body is of paramount importance in contrast-
enhanced magnetic resonance imaging (MRI). Optimal contrast agent performance is …

Gadolinium-based contrast agents have been used for magnetic resonance imaging (MRI)
examinations since the late 1980s with an excellent overall cumulative safety record. Initially …

“The gadolinium chelates (the GBCAs) are critical to disease diagnosis by MR, indeed to
clinical medicine worldwide, and have proven to be overall a very safe class of contrast …